# Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.

> **NCT00151645** · PHASE2 · TERMINATED · sponsor: **Rennes University Hospital** · enrollment: 36 (—)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **DRUG:** activated lymphocytes

## Key facts

- **NCT ID:** NCT00151645
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 36 (—)
- **Last updated:** 2006-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151645, "Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00151645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*